Trial Profile
Vx-001 vacine phase I clinical study in advanced cancer patients: analysis of the clinical response
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2007
Price :
$35
*
At a glance
- Drugs Vx 001 (Primary)
- Indications Cancer
- Focus Adverse reactions
- Sponsors Vaxon Biotech
- 06 Nov 2007 New trial record.